Related Experiment Video
Updated: Jun 28, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
[Morbidity/mortality review: usefulness and shortcomings]
M Gignon1, M-L Pibarot, M Sfez
1Département de Santé publique, CHU d'Amiens, place Victor-Pauchet - Amiens.
Physicians rarely use the Morbidity-Mortality Conference (MMC) methodology, citing lack of knowledge and time. Implementing MMC requires targeted education and support to enhance patient safety and care quality.
Area of Science:
- Healthcare Quality Improvement
- Patient Safety Research
- Clinical Risk Management
Context:
- The Morbidity-Mortality Conference (MMC) is a HAS-validated process for analyzing deaths and complications to enhance care quality and safety.
- Despite its validation and potential use in physician recredentialing and hospital accreditation, data on MMC implementation in France is scarce.
- A regional project aimed to assess physicians' experiences and perceptions of the MMC methodology in clinical risk management.
Purpose:
- To investigate the current implementation and physician perceptions of the Morbidity-Mortality Conference (MMC) methodology in French hospitals.
- To identify barriers and facilitators to the adoption of the MMC for improving patient care and safety.
- To understand physician motivations for implementing the MMC, particularly concerning patient safety and surgical care management.
Summary:
- A survey of 150 hospitals in northern France revealed that only 11% formally use the MMC methodology, with most adverse event analysis occurring in informal meetings (76%) or mandatory reports (77%).
- Key barriers to MMC adoption include lack of knowledge (66%) and time (50%), while fear of litigation was minimal (1%).
- Physicians view adverse event analysis as crucial for improving patient care (90%) and education (61%), leading to protocol modifications (70%) and organizational changes (71%).
Impact:
- Findings highlight a significant gap between the recognized importance of structured adverse event analysis and its actual implementation via the MMC methodology.
- The study underscores the need for specific educational initiatives and support systems to facilitate MMC adoption.
- Physician motivation for MMC implementation is primarily driven by patient safety concerns, suggesting that emphasizing these benefits can promote wider acceptance and effective use.
Related Concept Videos
Kaplan-Meier Approach
Methods of Documentation II: POMR
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Purpose of Health Records I
Here's a breakdown of how health records serve these purposes: